LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
Salk Institute for Biological Studies · University of California, Los Angeles · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
575
total citations
- FWCI
- 29.16
- Percentile
- 100%
- References
- 54
Citations per year
Authors
11- DBDavid B. ShackelfordCorresponding
Salk Institute for Biological Studies, University of California, Los Angeles, Center for Cancer Research
- EREvan R. Abt
University of California, Los Angeles
- LGLaurie Gerken
Salk Institute for Biological Studies, Center for Cancer Research
- DSDebbie S. Vasquez
Salk Institute for Biological Studies, Center for Cancer Research
- ASAtsuko Seki
University of California, Los Angeles
Topics & keywords
Topics
Keywords
- Phenformin
- Drug
- Cancer research
- Lung cancer
- Metabolism
- Cell
- Drug metabolism
- Cell metabolism
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.